Non-executive director

VIVOLTA Strengthens Leadership Team With New CEO and New Chairman to Drive Next Phase of Growth

Retrieved on: 
Giovedì, Novembre 30, 2023
Biotechnology, Health, Medical Devices, Attention, Acquisition, Organization, The Conference Board, Lead, Non-executive director, Master of Business Administration, Growth, HEC Paris, Avista Capital Partners, Pharmaceutical industry, Management

New CEO to Lead Strategic Initiatives:

Key Points: 
  • New CEO to Lead Strategic Initiatives:
    Denis Leissing has been appointed as the new Chief Executive Officer (CEO), taking over from Ramon Solberg, who held the position ad interim since 2022.
  • Mr. Leissing holds a master’s degree in mechanical engineering from ECAM Lyon, and an executive Master of business administration from HEC Paris.
  • Non-Executive Chairman of the Board Appointment:
    VIVOLTA has also appointed Rudy Mareel as the new Non-Executive Chairman of the Board, succeeding Fennemiek Gommer in this role.
  • “VIVOLTA is a truly global leader in the medical electrospinning sector, and it is an honor to be appointed as CEO.

Industry Veteran Abbas Hussain Appointed as Chair of Asceneuron

Retrieved on: 
Lunedì, Dicembre 18, 2023
SAN, Chair, Teva Pharmaceuticals, Abingworth (company), Patient, Adviser, Sofinnova, Spondyloarthropathy, Medicinal chemistry, Capital, CSL Limited, Stanford University, Eli Lilly, Pamlab, Conference, CSL Vifor, Non-executive director, Growth, GSK plc, OGA, Cochlear Limited, Pharmaceutical industry, Science, Immunocore

Abbas Hussain has over 35 years of experience in the healthcare industry, building and growing businesses across the globe.

Key Points: 
  • Abbas Hussain has over 35 years of experience in the healthcare industry, building and growing businesses across the globe.
  • Abbas Hussain, Chair of the Board of Directors of Asceneuron, remarked: "There have been tremendous advances in the treatment of neurodegenerative disorders which impact millions of people globally every year.
  • Abbas currently holds various Non-Executive Director and Advisor roles at Alfasigma SpA, 4Bio Capital, C-Bridge Capital and GLG Institute.
  • In addition, Abbas also provides expert advisory services to private equity and venture capital firms focused on the healthcare sector.

Industry Veteran Abbas Hussain Appointed as Chair of Asceneuron

Retrieved on: 
Lunedì, Dicembre 18, 2023
SAN, Chair, Teva Pharmaceuticals, Abingworth (company), Patient, Adviser, Sofinnova, Spondyloarthropathy, Medicinal chemistry, Capital, CSL Limited, Stanford University, Eli Lilly, Pamlab, Conference, CSL Vifor, Non-executive director, Growth, GSK plc, OGA, Cochlear Limited, Pharmaceutical industry, Science, Immunocore

Abbas Hussain has over 35 years of experience in the healthcare industry, building and growing businesses across the globe.

Key Points: 
  • Abbas Hussain has over 35 years of experience in the healthcare industry, building and growing businesses across the globe.
  • Abbas Hussain, Chair of the Board of Directors of Asceneuron, remarked: "There have been tremendous advances in the treatment of neurodegenerative disorders which impact millions of people globally every year.
  • Abbas currently holds various Non-Executive Director and Advisor roles at Alfasigma SpA, 4Bio Capital, C-Bridge Capital and GLG Institute.
  • In addition, Abbas also provides expert advisory services to private equity and venture capital firms focused on the healthcare sector.

Directorate change

Retrieved on: 
Domenica, Dicembre 10, 2023
Big Yellow Group, Capita, Regionals, Wallpaper group, William Hill (bookmaker), Britvic, Non-executive director, Senior, Advertising, Management

This appointment will be with effect from 26 January 2024, immediately following the Company’s AGM.

Key Points: 
  • This appointment will be with effect from 26 January 2024, immediately following the Company’s AGM.
  • A senior board member, she is currently the Senior Independent Director at Capita, where she has chaired the remuneration committee for the last four years.
  • Sue Clark was appointed Chair of the Remuneration Committee in September 2017, having first joined the Board in February 2016 as an independent Non-Executive Director.
  • She brings with her a wealth of talent and experience from her many non-executive director roles and her extensive executive career in media.

Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member

Retrieved on: 
Giovedì, Novembre 2, 2023
Sirona, McCombs School of Business, National Infrastructure Advisory Council, Dentistry, International, Health care, Millersville University of Pennsylvania, SABIC, Plastic, General Electric, Fortune 500, Information technology, XRAY, Business administration, Business, The Company, Non-executive director, University, Public Interest Declassification Board, CFO, Investment, Dell Technologies, Management, Science

CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the “Board”), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.’s retirement on December 31, 2023.

Key Points: 
  • CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the “Board”), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.’s retirement on December 31, 2023.
  • “On behalf of Dentsply Sirona and the Board of Directors, I am pleased to welcome Brian Gladden to the Board,” said Eric K. Brandt, Non-Executive Chairman of the Board.
  • “Brian brings more than 35 years of experience with a proven track record in setting strategic vision, building world-class organizations, and driving business growth and transformation.
  • As a CFO, Mr. Gladden has led all aspects of the finance function, M&A, information technology, security, facilities, and corporate strategy.

Marimaca Appoints Giancarlo Bruno Lagomarsino as Non-Executive Director

Retrieved on: 
Mercoledì, Novembre 1, 2023
Knowledge, Sale, Mantos Blancos mine, Mantoverde mine, Maintenance, Los Bronces mine, Anglo American, Senior, ExxonMobil, Non-executive director, Safety, Copper, TSX, Collahuasi mine, Mining, Giancarlo

VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the appointment of Giancarlo Bruno Lagomarsino as Non-Executive Director with immediate effect.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the appointment of Giancarlo Bruno Lagomarsino as Non-Executive Director with immediate effect.
  • Mr. Bruno Lagomarsino is a Chilean national and has spent all his 35-year career in Chilean copper operations.
  • Giancarlo was a member of the consortium that acquired Anglo Norte and became CEO of the entity, Mantos Copper SA, in June 2015.
  • Most recently, Mr. Bruno Lagomarsino was Senior VP of Capstone Copper in charge of its Chilean operations.

Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2023

Retrieved on: 
Martedì, Ottobre 31, 2023
Type, FDA, BMT, Inflammation, Mesoblast, Blood, Growth, MESO, Appendix, Chief Medical Officer (Australia), Executive, Non-executive director, MSB, Back pain, Transplant, Dietary supplement, Pharmaceutical industry, Bank

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the first quarter ended September 30, 2023.

Key Points: 
  • NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the first quarter ended September 30, 2023.
  • In this regard, we are working on corporate initiatives to strengthen our balance sheet, including royalty monetization and strategic partnerships to both access existing commercial distribution channels and supplement costs of development.
  • Cash balance at the end of the quarter was US$53.2 million, with net operating cash spend of US$14.2 million.
  • Revenue from royalties on sales of TEMCELL® HS Inj.2 sold in Japan by our licensee for the quarter were US$1.6 million.

Fosun International Awarded "Best Environmental, Social and Governance Reporting Awards" by The Hong Kong Management Association

Retrieved on: 
Lunedì, Novembre 6, 2023
Fosun International, Disclosure, Social, Global Compact, China Mobile, HKMA, GRI, Sustainable Development Goals, S&P Global, United Nations, Organization, Trust, Social responsibility, Risk management, Link REIT, MSCI, MTR Corporation, Sustainability, United Nations Global Compact, ESG, HSI, SGS, United, Sustainability Accounting Standards Board, SDG, Swire Properties, CLP Group, Biophysical environment, FTSE Russell, Hong Kong Stock Exchange, S&P Global Ratings, Tencent, UN, TCFD, Non-executive director, Property management, Management

HONG KONG, Nov. 6, 2023 /PRNewswire/ -- On 2 November 2023, The Hong Kong Management Association (HKMA) held the "2023 Best Annual Reports Awards" ceremony in Hong Kong.

Key Points: 
  • HONG KONG, Nov. 6, 2023 /PRNewswire/ -- On 2 November 2023, The Hong Kong Management Association (HKMA) held the "2023 Best Annual Reports Awards" ceremony in Hong Kong.
  • Fosun International was awarded the "Best Environmental, Social and Governance Reporting Awards" by HKMA, in recognition of the company's outstanding performance in ESG strategy, environmental protection, social responsibility, corporate governance and information disclosure by authoritative organization.
  • Fosun has always emphasized that corporate leaders should attach importance to ESG governance and establish an accountability system.
  • Fosun International received an AA MSCI ESG rating and was the only conglomerate in Greater China with such rating.

Navigator Holdings Ltd. Announces Changes to Board of Directors

Retrieved on: 
Giovedì, Ottobre 26, 2023
Audit committee, Chamber of commerce, NYSE, Business administration, Family, Adecco Group North America, Greater Houston, Commerce, Acquisition, MBA, American Staffing Association, Engineering, The Adecco Group, MPS, Business, Non-executive director, Pleasure, National Science Board, Cancer, Junior Achievement, Audit, Management, Science

Ms. Marx is a member of the board of directors of the American Staffing Association, Junior Achievement, CEOs Against Cancer, Greater Houston Women’s Chamber of Commerce, and Chair of Houston’s Bauer School of Business’ Business Engagement Committee.

Key Points: 
  • Ms. Marx is a member of the board of directors of the American Staffing Association, Junior Achievement, CEOs Against Cancer, Greater Houston Women’s Chamber of Commerce, and Chair of Houston’s Bauer School of Business’ Business Engagement Committee.
  • Ms. Marx holds a Bachelor of Science in Business Management and an MBA from Duke University’s Fuqua School of Business.
  • With these changes, the Company’s Board has increased from seven to eight members until November 15, 2023, the effective date of Mr. Kenwright’s resignation, upon which the size of the Company’s Board will decrease from eight to seven members.
  • We look forward to working with her closely during this exciting time for the Company.”

Clear Channel Outdoor Holdings, Inc. Signs Share Purchase Agreement to Sell its France Business to Equinox Industries

Retrieved on: 
Mercoledì, Ottobre 18, 2023
Equinox, Partner, Golf Channel France, NYSE, CCO, Clear, Growth, EUR, Non-executive director, Senior advisor, Investment, Airport, SAN, Retail

SAN ANTONIO, Oct. 18, 2023 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) (the "Company") today announced that it has signed a share purchase agreement to sell its business in France to Equinox Industries ("Equinox"), a Paris-based industrial holding company that makes long-term majority equity investments. Equinox's Managing Partners, Charles-Henri Rossignol and Thibaud Caulier, have more than 20 years of investing and operating experience. In addition, Didier Quillot, Equinox's Senior Advisor, would participate alongside Equinox Industries in the proposed transaction and would be appointed Non-Executive Chairman of Clear Channel France upon completion.

Key Points: 
  • SAN ANTONIO, Oct. 18, 2023 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) (the "Company") today announced that it has signed a share purchase agreement to sell its business in France to Equinox Industries ("Equinox"), a Paris-based industrial holding company that makes long-term majority equity investments.
  • In addition, Didier Quillot, Equinox's Senior Advisor, would participate alongside Equinox Industries in the proposed transaction and would be appointed Non-Executive Chairman of Clear Channel France upon completion.
  • "We are excited by this potential opportunity to grow Clear Channel France's established position and experienced leadership in the French outdoor advertising space," said Messrs. Rossignol and Caulier.
  • As consideration for the transaction, the Company would deliver Clear Channel France to Equinox Industries at closing with approximately EUR 42 million of cash, subject to adjustment for related customary items, tax and other costs, to support ongoing operations of the business, and Equinox Industries would maintain the approximately EUR 30 million state-guaranteed loan held by Clear Channel France.